Brind.

Jean-Paul Kress was appointed CEO and Chairman of the Board of VOR.

5 reports, 2 independent Updated Sep 2
Gone quiet Reached 2 outlets in its first 24 hours
Reports
5
Developments
1
Repetition
80%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Jean-Paul Kress was appointed CEO and Chairman of the Board of VOR.

Who's involved

What this event is mainly about
Jean-Paul KressVOR

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireVor Bio Appoints Adi Osovsky, S.J.D. as General Counsel Experienced legal leader brings deep expertise in governance, strategic transactions, and risk management to support Vor Bio’s growth CAMBRIDGE
  • BenzingaVor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial On Wednesday, Vor Bio Inc. (NASDAQ:VOR) announced that its collaborator, RemeGen Co., Ltd., achieved the primary e
  • GlobeNewswireTelitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for IgA Nephropathy Results reinforce telitacicept’s potential across multiple autoimmune diseases Data anticipated to be presented at
  • GlobeNewswireVor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pi
  • Unknown outlet